Effect of Breather in COPD Patients With Intermittent Claudication

Cairo University60 enrolled

Overview

The aim of this study To show the effect of breather on ventilatory and vascular function in COPD patient with intermittent claudication.

recent researches show that COPD patients have risk of developing peripheral arterial disease (PAD) which represented on patient by intermittent claudication inspiratory muscle trainer as the breather device show increasing in inspiratory muscle strength and endurance; reduction of dyspnea; and improving of exercise tolerance . Because of all this things this study tends to show the effect of the breather on ventilatory and vascular function in COPD patient with intermittent claudication.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

QUADRUPLE

Enrollment

Conditions

COPD PAD

Interventions

The BREATHERDEVICE

The BREATHER is Light/Medium resistance inspiratory muscle trainer which has significance role in increasing inspiratory muscle strength and endurance which could result in a decreased sensation of dyspnea

pharmacological treatmentDRUG

patient will receive the usually pharmacological treatment.

Eligibility

Sex: MALEMin age: 50 YearsMax age: 60 Years

Medical Language ↔ Plain English

Inclusion Criteria: * sixty male patients with diagnosed with grade I and grade II COPD their ages ranged between 55-60years * All patients will be clinically and medically stable when attending the study. * Body mass index (BMI) is 18.5 to 24.9 kg/m2. * History of unilateral exertional leg pain, * Ambulation during a graded treadmill test limited by leg pain consistent with intermittent claudication (stage II of the fontaine classification of pad), * And an ankle-brachial index (ABI) of 0.90 or lower at rest or 0.73 or lower after exercise. Exclusion Criteria: * cardiovascular insufficiency, * Recent myocardial infarction, * heart failure, * arrhythmia, * DVT, * Intracranial hypertension, * Pneumonia, * kidney failure, * fractures, * uncooperative patients, * cognitive impairment preventing a patient from participation in exercises.

Locations (1)

Faculty of Physical Therapy

Dokki, Egypt

RECRUITING

Outcomes

Primary Outcomes

Ventilatory function: by spirometry test

Spirometry is a physiological test that measures the ability to inhale and exhale air relative to time.

Time frame: 4 weeks

Vascular function: by doppler ultrasound

Doppler ultrasound is a simple and non-invasive and method for the evaluation of early atherosclerosis. It can be used as a screening program for PAD in populations with high risk for atherosclerosis.

Time frame: 4 weeks

Secondary Outcomes

Functional capacity assessment: by 5 repetitions sit to stand test (5R-STS)

(5R-STS) test is an objective test of functional impairment commonly used in various diseases including COPD which is used to measure the severity of disease and to monitor recovery.

Time frame: 4 weeks

Treadmill exercise testing

The results of the tests will be expressed in units of distance that will be walked up to the claudication pain (initial claudication distance) and the maximally tolerated claudication pain (maximal claudication distance).

Time frame: 4 weeks

Central Contacts

Reem M Farahat, student

CONTACT

+201050770870 Reemfarahat42@gmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.